[{"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-001", "question": "A 45-year-old woman presents with progressive bilateral hearing loss, facial numbness, and ataxia. MRI reveals bilateral enhancing cerebellopontine angle masses with significant brainstem compression. Genetic testing confirms a missense mutation in the SMARCB1 gene. After maximal safe resection of the larger tumor, which management strategy offers the best long-term tumor control while preserving neurological function?", "options": ["Treatment with a selective histone deacetylase 6 (HDAC6) inhibitor", "Initiation of mTOR complex 1/2 dual inhibitor therapy", "Conformal radiotherapy targeting both lesions with dose painting", "Observation with serial MRI and consideration of bevacizumab for symptom control", "Prophylactic ventriculoperitoneal shunting followed by chemotherapy with carboplatin/vincristine"], "answer": "A", "answer_index": 0, "explanation": "The clinical scenario describes schwannomatosis due to SMARCB1 mutation. HDAC6 inhibitors have shown specific efficacy in preclinical models of SMARCB1-deficient tumors by restoring protein homeostasis and inducing apoptosis, unlike broader epigenetic modifiers. mTOR inhibitors are more relevant for NF2-related schwannomas, while radiotherapy is contraindicated in schwannomatosis due to malignant transformation risk. Bevacizumab has limited efficacy in SMARCB1-mutant tumors compared to NF2-mutant schwannomas.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. The vignette describes bilateral cerebellopontine angle masses with SMARCB1 mutation, suggesting schwannomatosis. However, the keyed answer (HDAC6 inhibitor) is based on preclinical data only and is not standard care. Key stem clues: bilateral CPA masses, SMARCB1 mutation, post-resection management needed. The rationale claims radiotherapy is contraindicated due to malignant transformation risk in schwannomatosis, but this is not well-established in medical literature. In fact, stereotactic radiosurgery is commonly used for schwannomas including in schwannomatosis when surgery is not feasible. Option C (conformal radiotherapy) represents current standard practice for residual/bilateral vestibular schwannomas. The claim that HDAC6 inhibitors have proven efficacy is unsupported - these remain investigational with no FDA approval or established clinical benefit. Option B (mTOR inhibitors) also lacks strong evidence in schwannomatosis. Main logical issue: the keyed answer relies on experimental therapy over established treatment. Main medical accuracy issue: mischaracterization of radiotherapy contraindication and promotion of unproven therapy as best option. Minimal fix: Change key to C or reframe question to ask about investigational approaches specifically, not 'best long-term tumor control.'\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. The vignette describes bilateral cerebellopontine angle masses with SMARCB1 mutation, suggesting schwannomatosis. However, the keyed answer (HDAC6 inhibitor) is based on preclinical data only and is not standard care. Key stem clues: bilateral CPA masses, SMARCB1 mutation, post-resection management needed. The rationale claims radiotherapy is contraindicated due to malignant transformation risk in schwannomatosis, but this is not well-established in medical literature. In fact, stereotactic radiosurgery is commonly used for schwannomas including in schwannomatosis when surgery is not feasible. Option C (conformal radiotherapy) represents current standard practice for residual/bilateral vestibular schwannomas. The claim that HDAC6 inhibitors have proven efficacy is unsupported - these remain investigational with no FDA approval or established clinical benefit. Option B (mTOR inhibitors) also lacks strong evidence in schwannomatosis. Main logical issue: the keyed answer relies on experimental therapy over established treatment. Main medical accuracy issue: mischaracterization of radiotherapy contraindication and promotion of unproven therapy as best option. Minimal fix: Change key to C or reframe question to ask about investigational approaches specifically, not 'best long-term tumor control.'", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-002", "question": "A 68-year-old man with locally advanced pancreatic cancer involving the celiac axis undergoes stereotactic body radiotherapy (SBRT) to 40 Gy in 5 fractions. Three months later, he develops severe epigastric pain and hematemesis. Endoscopy reveals a deeply ulcerated lesion in the gastric antrum with visible vessel. Biopsy shows radiation-induced changes without malignancy. Which interventional approach is most likely to achieve durable hemostasis while minimizing the risk of gastric perforation?", "options": ["Over-the-scope clip placement with concomitant fibrin glue injection", "Hybrid argon plasma coagulation combined with topical hemostatic powder", "Selective angiography with coil embolization of the gastroduodenal artery", "Endoscopic ultrasound-guided cyanoacrylate injection into the peri-ulcer bed", "Temporary covered esophageal stent placement with nasojejunal feeding tube"], "answer": "D", "answer_index": 3, "explanation": "After high-dose SBRT, conventional endoscopic therapies often fail due to compromised tissue healing. EUS-guided cyanoacrylate injection directly targets the feeding vessel deep within the ulcer bed, creating a permanent seal without the tissue disruption caused by thermal modalities. Over-the-scope clips may not hold in friable irradiated tissue, while angiographic embolization risks non-target ischemia. Topical agents provide only temporary control in this high-flow scenario.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option C is the best answer, not D. The vignette describes a 68-year-old with radiation-induced gastric ulcer showing visible vessel and hematemesis after pancreatic SBRT. Key discriminating findings: (1) post-radiation tissue with compromised healing, (2) active bleeding with visible vessel, (3) deeply ulcerated lesion in friable tissue. For high-risk bleeding with visible vessel in radiation-damaged tissue, selective angiography with coil embolization (C) is the gold standard, offering durable hemostasis without manipulating friable tissue prone to perforation. The keyed answer (D) - EUS-guided cyanoacrylate injection - is problematic: cyanoacrylate is primarily used for gastric varices, not arterial bleeding from ulcers; injection into radiation-damaged peri-ulcer bed risks perforation and lacks established efficacy for this indication. Option A (clips) may fail in friable tissue as noted. Option B (APC/powder) provides temporary control. Option E (esophageal stent) is anatomically mismatched for gastric antrum bleeding. The rationale incorrectly dismisses angioembolization citing 'non-target ischemia' risk, but this is the standard approach for refractory ulcer bleeding, especially in poor surgical candidates with radiation-damaged tissue. Medical accuracy issue: mischaracterization of cyanoacrylate's role and dismissal of angioembolization. Minimal fix: Change key to C or rewrite to specify variceal bleeding scenario.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option C is the best answer, not D. The vignette describes a 68-year-old with radiation-induced gastric ulcer showing visible vessel and hematemesis after pancreatic SBRT. Key discriminating findings: (1) post-radiation tissue with compromised healing, (2) active bleeding with visible vessel, (3) deeply ulcerated lesion in friable tissue. For high-risk bleeding with visible vessel in radiation-damaged tissue, selective angiography with coil embolization (C) is the gold standard, offering durable hemostasis without manipulating friable tissue prone to perforation. The keyed answer (D) - EUS-guided cyanoacrylate injection - is problematic: cyanoacrylate is primarily used for gastric varices, not arterial bleeding from ulcers; injection into radiation-damaged peri-ulcer bed risks perforation and lacks established efficacy for this indication. Option A (clips) may fail in friable tissue as noted. Option B (APC/powder) provides temporary control. Option E (esophageal stent) is anatomically mismatched for gastric antrum bleeding. The rationale incorrectly dismisses angioembolization citing 'non-target ischemia' risk, but this is the standard approach for refractory ulcer bleeding, especially in poor surgical candidates with radiation-damaged tissue. Medical accuracy issue: mischaracterization of cyanoacrylate's role and dismissal of angioembolization. Minimal fix: Change key to C or rewrite to specify variceal bleeding scenario.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-003", "question": "A 52-year-old man undergoes right pneumonectomy for T3N2M0 non-small cell lung cancer. On postoperative day 4, he develops acute respiratory distress. Chest tube output abruptly decreases, and the mediastinum shifts toward the left on radiograph. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump without frank disruption. What is the most appropriate immediate management?", "options": ["Emergency rethoracotomy with direct stump revision", "Placement of a second chest tube to water seal", "Immediate bedside reopening of the incision with antibiotic irrigation", "Flexible bronchoscopic placement of an endobronchial valve in the right main bronchus", "Urgent veno-venous ECMO cannulation followed by operative repair"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes a post-pneumonectomy bronchopleural fistula with impending tension physiology. Immediate bedside reopening allows mediastinal decompression and converts the situation to an open pleural cavity, preventing fatal tension. This is followed by formal operative repair after stabilization. Endobronchial valves are ineffective for large proximal dehiscences. Re-thoracotomy without decompression risks cardiovascular collapse. ECMO is reserved for refractory respiratory failure after initial stabilization.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: post-pneumonectomy day 4, acute respiratory distress, abrupt decrease in chest tube output, mediastinal shift toward left (contralateral to pneumonectomy side), 1.5 cm bronchial stump dehiscence on bronchoscopy. The clinical picture describes post-pneumonectomy bronchopleural fistula (BPF) with tension physiology in the pneumonectomy space causing contralateral mediastinal shift. The rationale claims immediate bedside reopening (C) allows mediastinal decompression, but this is medically incorrect. Standard management of tension in a pneumonectomy space is urgent needle aspiration or chest tube placement to water seal (B), NOT opening the incision. Opening the thoracotomy incision bedside does not effectively decompress a pneumonectomy space and risks contamination without addressing the air leak. Option B (second chest tube to water seal) is the correct immediate intervention to relieve tension, followed by definitive surgical repair. The item confuses emergency management of empyema (which may require open drainage) with tension physiology requiring decompression. Main medical accuracy issue: keyed answer represents dangerous management that fails to address tension physiology appropriately. Minimal fix: Change key to B or rewrite stem to describe empyema rather than tension.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: post-pneumonectomy day 4, acute respiratory distress, abrupt decrease in chest tube output, mediastinal shift toward left (contralateral to pneumonectomy side), 1.5 cm bronchial stump dehiscence on bronchoscopy. The clinical picture describes post-pneumonectomy bronchopleural fistula (BPF) with tension physiology in the pneumonectomy space causing contralateral mediastinal shift. The rationale claims immediate bedside reopening (C) allows mediastinal decompression, but this is medically incorrect. Standard management of tension in a pneumonectomy space is urgent needle aspiration or chest tube placement to water seal (B), NOT opening the incision. Opening the thoracotomy incision bedside does not effectively decompress a pneumonectomy space and risks contamination without addressing the air leak. Option B (second chest tube to water seal) is the correct immediate intervention to relieve tension, followed by definitive surgical repair. The item confuses emergency management of empyema (which may require open drainage) with tension physiology requiring decompression. Main medical accuracy issue: keyed answer represents dangerous management that fails to address tension physiology appropriately. Minimal fix: Change key to B or rewrite stem to describe empyema rather than tension.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-004", "question": "A 74-year-old man with a history of abdominal aortic aneurysm repair presents with acute onset of painful blue discoloration of his toes despite palpable pedal pulses. Laboratory studies show elevated creatinine kinase and acute kidney injury. Angiography demonstrates patent bypass graft but diffuse microvascular occlusion in both feet. What is the most appropriate emergent intervention?", "options": ["Immediate bilateral sympathectomy", "Systemic heparinization followed by catheter-directed thrombolysis", "High-dose corticosteroid pulse therapy", "Emergent surgical embolectomy of the tibial vessels", "Plasma exchange with albumin replacement"], "answer": "E", "answer_index": 4, "explanation": "The presentation is consistent with cholesterol embolization syndrome following aortic manipulation. Plasma exchange removes inflammatory mediators and cholesterol-laden microemboli, improving microcirculatory flow. Thrombolysis is ineffective for cholesterol crystals and increases hemorrhage risk. Sympathectomy helps vasospasm but doesn't address the embolic load. Corticosteroids may modestly reduce inflammation but don't remove emboli. Surgical embolectomy cannot access distal microvasculature.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. The vignette describes classic cholesterol embolization syndrome (blue toe syndrome with palpable pulses, post-aortic procedure, AKI). Key discriminating findings: post-AAA repair, painful blue toes, intact pedal pulses, elevated CK, AKI, diffuse microvascular occlusion on angiography. The question asks for \\\"most appropriate emergent intervention.\\\" While the rationale correctly identifies cholesterol embolization, plasma exchange (E) is NOT standard emergent therapy for this condition. Cholesterol embolization is primarily managed supportively with antiplatelet agents, statins, and avoidance of further vascular manipulation. Plasma exchange lacks robust evidence and is not guideline-recommended for acute cholesterol embolization. Systemic heparinization (B) is contraindicated as anticoagulation can worsen cholesterol embolization. However, the stem's emphasis on \\\"emergent intervention\\\" for a condition that typically requires supportive care creates ambiguity. None of the options represent true standard-of-care emergent management. The item appears to test knowledge of cholesterol embolization but offers no medically defensible emergent intervention among the choices. Minimal fix: Reframe as \\\"most appropriate next step in management\\\" and include supportive care with antiplatelet therapy as an option, or clarify that no emergent intervention beyond supportive measures is indicated.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. The vignette describes classic cholesterol embolization syndrome (blue toe syndrome with palpable pulses, post-aortic procedure, AKI). Key discriminating findings: post-AAA repair, painful blue toes, intact pedal pulses, elevated CK, AKI, diffuse microvascular occlusion on angiography. The question asks for \"most appropriate emergent intervention.\" While the rationale correctly identifies cholesterol embolization, plasma exchange (E) is NOT standard emergent therapy for this condition. Cholesterol embolization is primarily managed supportively with antiplatelet agents, statins, and avoidance of further vascular manipulation. Plasma exchange lacks robust evidence and is not guideline-recommended for acute cholesterol embolization. Systemic heparinization (B) is contraindicated as anticoagulation can worsen cholesterol embolization. However, the stem's emphasis on \"emergent intervention\" for a condition that typically requires supportive care creates ambiguity. None of the options represent true standard-of-care emergent management. The item appears to test knowledge of cholesterol embolization but offers no medically defensible emergent intervention among the choices. Minimal fix: Reframe as \"most appropriate next step in management\" and include supportive care with antiplatelet therapy as an option, or clarify that no emergent intervention beyond supportive measures is indicated.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-005", "question": "A 38-year-old woman with Crohn's disease maintained on vedolizumab presents with recurrent episodes of postprandial abdominal pain and 15-pound weight loss. CT enterography shows patent superior mesenteric artery and vein. Gastric emptying study is normal. Diagnostic laparoscopy reveals no adhesions. Which test will most likely establish the diagnosis?", "options": ["Mesenteric Doppler ultrasound with a standardized meal challenge", "Lactulose hydrogen breath test for small intestinal bacterial overgrowth", "Serum tryptase level during symptomatic episode", "Selective mesenteric angiography with vasodilator challenge", "Video capsule endoscopy with patency capsule confirmation"], "answer": "A", "answer_index": 0, "explanation": "This presentation suggests chronic mesenteric ischemia despite patent gross vasculature, possibly from vedolizumab-associated microvascular dysfunction. Provocative mesenteric Doppler can demonstrate reduced postprandial flow reserve. While bacterial overgrowth is common in Crohn's, it doesn't explain the postprandial timing. Angiography shows macrovascular disease already ruled out. Capsule endoscopy may show mucosal changes but doesn't assess flow dynamics. Tryptase would indicate mast cell disorder, which is less likely.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes postprandial pain and weight loss in a Crohn's patient on vedolizumab, with normal CT angiography (patent vessels), normal gastric emptying, and no adhesions. The keyed answer (A: mesenteric Doppler with meal challenge) assumes microvascular mesenteric ischemia despite patent macrovessels—a rare entity requiring provocative testing. However, option B (SIBO breath test) is equally defensible: Crohn's disease predisposes to SIBO via strictures/dysmotility; SIBO classically causes postprandial bloating/pain and malabsorption (weight loss); the normal gastric emptying doesn't exclude small bowel bacterial overgrowth. The stem lacks discriminating findings (e.g., diarrhea favoring SIBO, severe postprandial pain out of proportion to exam favoring ischemia, or evidence of strictures). Option E (capsule endoscopy) could reveal active Crohn's inflammation/strictures causing symptoms. The rationale's claim that SIBO 'doesn't explain postprandial timing' is medically inaccurate—SIBO symptoms are characteristically postprandial. Main issue: underspecification (no details excluding SIBO or confirming microvascular disease) leading to multiple defensible answers. Minimal fix: Add stem clues such as 'severe cramping pain within 30 minutes of eating, relieved by fasting' (ischemia) or 'chronic diarrhea, bloating' (SIBO) to discriminate.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes postprandial pain and weight loss in a Crohn's patient on vedolizumab, with normal CT angiography (patent vessels), normal gastric emptying, and no adhesions. The keyed answer (A: mesenteric Doppler with meal challenge) assumes microvascular mesenteric ischemia despite patent macrovessels—a rare entity requiring provocative testing. However, option B (SIBO breath test) is equally defensible: Crohn's disease predisposes to SIBO via strictures/dysmotility; SIBO classically causes postprandial bloating/pain and malabsorption (weight loss); the normal gastric emptying doesn't exclude small bowel bacterial overgrowth. The stem lacks discriminating findings (e.g., diarrhea favoring SIBO, severe postprandial pain out of proportion to exam favoring ischemia, or evidence of strictures). Option E (capsule endoscopy) could reveal active Crohn's inflammation/strictures causing symptoms. The rationale's claim that SIBO 'doesn't explain postprandial timing' is medically inaccurate—SIBO symptoms are characteristically postprandial. Main issue: underspecification (no details excluding SIBO or confirming microvascular disease) leading to multiple defensible answers. Minimal fix: Add stem clues such as 'severe cramping pain within 30 minutes of eating, relieved by fasting' (ischemia) or 'chronic diarrhea, bloating' (SIBO) to discriminate.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-006", "question": "A 65-year-old man presents with acute severe hematochezia. Colonoscopy reveals active bleeding from a non-ulcerated lesion in the ascending colon with a visible vessel. Biopsy shows dilated submucosal veins without evidence of vasculitis or neoplasia. CT angiography shows no arterial malformation. What is the most appropriate endoscopic therapy?", "options": ["Heater probe coagulation with high power settings", "Endoscopic band ligation of the lesion", "Injection of N-butyl-2-cyanoacrylate glue", "Placement of through-the-scope clips in a circumferential pattern", "Argon plasma coagulation with extended application time"], "answer": "B", "answer_index": 1, "explanation": "The findings are characteristic of Dieulafoy's lesion of the colon, which involves a abnormally large submucosal artery. Endoscopic band ligation is superior to thermal or clipping methods as it mechanically secures the vessel with low recurrence rates. Cyanoacrylate injection risks embolization in this location. Thermal methods may not adequately coagulate the large caliber vessel. Clips may not achieve full-thickness compression needed for this lesion type.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical scenario. Key stem clues: 65-year-old with acute severe hematochezia, non-ulcerated lesion in ascending colon with visible vessel, biopsy showing dilated submucosal VEINS (not arteries), no arterial malformation on CT angiography. The vignette describes an angiodysplasia (vascular ectasia) with dilated submucosal veins, NOT a Dieulafoy lesion. Dieulafoy lesions are characterized by abnormally large submucosal ARTERIES that erode through the mucosa, typically presenting with arterial bleeding and visible vessel stumps. The pathology explicitly states dilated submucosal veins and CT shows no arterial malformation, directly contradicting the Dieulafoy diagnosis claimed in the rationale. For colonic angiodysplasia with active bleeding and visible vessel, argon plasma coagulation (E) or heater probe (A) are standard first-line therapies. Band ligation (B) is appropriate for Dieulafoy lesions but not standard for venous angiodysplasias. The item has internal medical logic but the key is mismatched to the actual pathology described. Minimal fix: Either change the pathology to 'abnormally large submucosal artery' to support answer B, or change the key to A or E to match the angiodysplasia described.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical scenario. Key stem clues: 65-year-old with acute severe hematochezia, non-ulcerated lesion in ascending colon with visible vessel, biopsy showing dilated submucosal VEINS (not arteries), no arterial malformation on CT angiography. The vignette describes an angiodysplasia (vascular ectasia) with dilated submucosal veins, NOT a Dieulafoy lesion. Dieulafoy lesions are characterized by abnormally large submucosal ARTERIES that erode through the mucosa, typically presenting with arterial bleeding and visible vessel stumps. The pathology explicitly states dilated submucosal veins and CT shows no arterial malformation, directly contradicting the Dieulafoy diagnosis claimed in the rationale. For colonic angiodysplasia with active bleeding and visible vessel, argon plasma coagulation (E) or heater probe (A) are standard first-line therapies. Band ligation (B) is appropriate for Dieulafoy lesions but not standard for venous angiodysplasias. The item has internal medical logic but the key is mismatched to the actual pathology described. Minimal fix: Either change the pathology to 'abnormally large submucosal artery' to support answer B, or change the key to A or E to match the angiodysplasia described.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-007", "question": "A 55-year-old man with autosomal dominant polycystic kidney disease (ADPKD) and estimated glomerular filtration rate of 35 mL/min/1.73m² presents with acute left flank pain. CT shows a 8cm left renal cyst with hyperdense material and a fluid-debris level. Urinalysis shows 25-50 white blood cells but no bacteria. He is afebrile with normal blood pressure. What is the most appropriate management?", "options": ["Immediate initiation of ciprofloxacin", "Percutaneous drainage with cyst fluid culture", "CT-guided aspiration for cytology", "Hospital admission for intravenous ampicillin-sulbactam", "Analgesia and follow-up imaging in 4-6 weeks"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests an infected renal cyst in ADPKD, which requires drainage for both diagnosis and therapy. Cyst infections often present with minimal systemic signs in ADPKD patients. Antibiotics alone penetrate cysts poorly. Percutaneous drainage confirms the diagnosis, provides targeted therapy, and prevents sepsis. Aspiration for cytology would miss infection. Observation risks abscess formation. IV antibiotics without drainage are unlikely to eradicate the infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 55-year-old ADPKD patient with acute flank pain, an 8cm cyst with hyperdense material and fluid-debris level, sterile pyuria (25-50 WBCs, no bacteria), afebrile, normotensive. Key discriminating findings: hyperdense material suggests hemorrhage or infection; fluid-debris level and pyuria suggest infection; absence of fever/bacteria creates diagnostic ambiguity. The stem does not definitively establish infected cyst versus hemorrhagic cyst. Both B (percutaneous drainage) and E (conservative management with follow-up) are defensible. For infected cyst, drainage is standard (supports B). However, the patient is clinically stable (afebrile, normotensive, CKD3b), and sterile pyuria with no bacteria could represent hemorrhagic cyst with inflammatory response rather than true infection. In stable ADPKD patients with suspected cyst complications, initial conservative management with close monitoring is reasonable, reserving drainage for clinical deterioration or confirmed infection. The rationale assumes infection but the vignette lacks fever, positive cultures, or clear sepsis risk requiring immediate intervention. Medical accuracy: The teaching point about cyst infection management is sound (score 4), but the clinical presentation is ambiguous. Minimal fix: Add fever >38°C or positive blood cultures to definitively indicate infected cyst requiring drainage.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 55-year-old ADPKD patient with acute flank pain, an 8cm cyst with hyperdense material and fluid-debris level, sterile pyuria (25-50 WBCs, no bacteria), afebrile, normotensive. Key discriminating findings: hyperdense material suggests hemorrhage or infection; fluid-debris level and pyuria suggest infection; absence of fever/bacteria creates diagnostic ambiguity. The stem does not definitively establish infected cyst versus hemorrhagic cyst. Both B (percutaneous drainage) and E (conservative management with follow-up) are defensible. For infected cyst, drainage is standard (supports B). However, the patient is clinically stable (afebrile, normotensive, CKD3b), and sterile pyuria with no bacteria could represent hemorrhagic cyst with inflammatory response rather than true infection. In stable ADPKD patients with suspected cyst complications, initial conservative management with close monitoring is reasonable, reserving drainage for clinical deterioration or confirmed infection. The rationale assumes infection but the vignette lacks fever, positive cultures, or clear sepsis risk requiring immediate intervention. Medical accuracy: The teaching point about cyst infection management is sound (score 4), but the clinical presentation is ambiguous. Minimal fix: Add fever >38°C or positive blood cultures to definitively indicate infected cyst requiring drainage.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-008", "question": "A 28-year-old woman develops recurrent sinopulmonary infections and bronchiectasis. Workup reveals absent IgA, markedly reduced IgG and IgM, and absent B cells on flow cytometry. Genetic testing identifies a mutation in the λ5 surrogate light chain gene. Which specific immunological abnormality explains her infection pattern?", "options": ["Failure of heavy chain rearrangement in pre-B cells", "Defective VDJ recombination due to RAG deficiency", "Absence of the pre-B cell receptor complex signaling", "Mutation in the BLNK adapter protein preventing PLCγ activation", "Loss of BTK enzyme function disrupting B cell maturation"], "answer": "C", "answer_index": 2, "explanation": "The λ5 gene encodes part of the surrogate light chain critical for pre-B cell receptor formation. Without functional pre-BCR signaling, B cells fail to proliferate and mature at the pre-B cell stage, causing the arrested development seen here. This is distinct from Bruton's tyrosine kinase deficiency (which affects later signaling) or RAG deficiencies (which impair initial recombination). The specific λ5 mutation explains the profound B cell deficiency and hypogammaglobulinemia.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 28-year-old woman with recurrent sinopulmonary infections, bronchiectasis, absent IgA, markedly reduced IgG/IgM, absent B cells, and a λ5 surrogate light chain gene mutation. Key discriminating findings: (1) absent B cells on flow cytometry indicating arrested B cell development, (2) hypogammaglobulinemia across all isotypes, (3) specific λ5 mutation. The λ5 gene encodes the surrogate light chain component of the pre-B cell receptor (pre-BCR) complex. Without functional λ5, the pre-BCR cannot form, preventing the critical checkpoint signaling required for pre-B cell proliferation and progression to immature B cells. This explains the complete absence of mature B cells and resulting agammaglobulinemia. Option C correctly identifies absence of pre-BCR complex signaling as the mechanism. Option A is incorrect—heavy chain rearrangement occurs before pre-BCR formation and would not be specifically affected by λ5 mutation. Option B (RAG deficiency) would prevent all VDJ recombination, affecting T cells as well. Option D (BLNK) and E (BTK/Bruton's) affect downstream signaling but would not prevent pre-BCR formation itself. The item is medically accurate, logically sound, and the key is correct. No fix needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 28-year-old woman with recurrent sinopulmonary infections, bronchiectasis, absent IgA, markedly reduced IgG/IgM, absent B cells, and a λ5 surrogate light chain gene mutation. Key discriminating findings: (1) absent B cells on flow cytometry indicating arrested B cell development, (2) hypogammaglobulinemia across all isotypes, (3) specific λ5 mutation. The λ5 gene encodes the surrogate light chain component of the pre-B cell receptor (pre-BCR) complex. Without functional λ5, the pre-BCR cannot form, preventing the critical checkpoint signaling required for pre-B cell proliferation and progression to immature B cells. This explains the complete absence of mature B cells and resulting agammaglobulinemia. Option C correctly identifies absence of pre-BCR complex signaling as the mechanism. Option A is incorrect—heavy chain rearrangement occurs before pre-BCR formation and would not be specifically affected by λ5 mutation. Option B (RAG deficiency) would prevent all VDJ recombination, affecting T cells as well. Option D (BLNK) and E (BTK/Bruton's) affect downstream signaling but would not prevent pre-BCR formation itself. The item is medically accurate, logically sound, and the key is correct. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-009", "question": "A 42-year-old immigrant from rural Venezuela presents with progressive dyspnea and hemoptysis. Echocardiography shows severe pulmonary hypertension with right ventricular hypertrophy. Serology is positive for Strongyloides stercoralis antibodies. CT chest reveals diffuse ground-glass opacities with bronchial wall thickening. What is the most appropriate initial treatment?", "options": ["Ivermectin alone", "Ivermectin plus prednisone", "Albendazole plus diethylcarbamazine", "Praziquantel followed by ivermectin", "Thiabendazole with gradual pulmonary vasodilator therapy"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests Strongyloides hyperinfection syndrome with associated pulmonary involvement. Treatment requires both anthelminthic therapy (ivermectin) and corticosteroids to prevent lethal inflammatory response from dying larvae (paradoxical worsening). Using ivermectin alone risks fatal inflammatory reaction. Albendazole is less effective for Strongyloides. Praziquantel treats schistosomiasis, not strongyloidiasis. Vasodilators don't address the underlying parasitic infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the provided key contradicts standard medical practice. The stem describes a patient with Strongyloides stercoralis infection presenting with severe pulmonary manifestations. Key discriminating findings: immigrant from endemic area, positive Strongyloides serology, pulmonary hypertension, ground-glass opacities. The clinical problem is determining appropriate initial treatment for strongyloidiasis with pulmonary involvement. The keyed answer (B: Ivermectin plus prednisone) is medically dangerous. Corticosteroids are CONTRAINDICATED in Strongyloides infection because immunosuppression can trigger hyperinfection syndrome or disseminated disease, which is often fatal. The rationale's claim that corticosteroids prevent inflammatory response from dying larvae is incorrect - this confuses Strongyloides with other helminthic infections (e.g., neurocysticercosis, onchocerciasis). Standard treatment for strongyloidiasis is ivermectin alone (option A), which is the correct answer. The item contains a fundamental medical error that could lead to harmful clinical decisions. Minimal fix: Change the correct answer key from B to A, and revise the rationale to reflect that ivermectin monotherapy is standard care and corticosteroids are contraindicated unless already being taken (in which case they should be continued during treatment).\", \"medical_accuracy_score\": \"1\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the provided key contradicts standard medical practice. The stem describes a patient with Strongyloides stercoralis infection presenting with severe pulmonary manifestations. Key discriminating findings: immigrant from endemic area, positive Strongyloides serology, pulmonary hypertension, ground-glass opacities. The clinical problem is determining appropriate initial treatment for strongyloidiasis with pulmonary involvement. The keyed answer (B: Ivermectin plus prednisone) is medically dangerous. Corticosteroids are CONTRAINDICATED in Strongyloides infection because immunosuppression can trigger hyperinfection syndrome or disseminated disease, which is often fatal. The rationale's claim that corticosteroids prevent inflammatory response from dying larvae is incorrect - this confuses Strongyloides with other helminthic infections (e.g., neurocysticercosis, onchocerciasis). Standard treatment for strongyloidiasis is ivermectin alone (option A), which is the correct answer. The item contains a fundamental medical error that could lead to harmful clinical decisions. Minimal fix: Change the correct answer key from B to A, and revise the rationale to reflect that ivermectin monotherapy is standard care and corticosteroids are contraindicated unless already being taken (in which case they should be continued during treatment).", "medical_accuracy_score": 1, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 1}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-010", "question": "A 65-year-old liver transplant recipient on tacrolimus, mycophenolate, and prednisone presents with altered mental status and focal neurological deficits. MRI shows multiple ring-enhancing lesions with eccentric target sign. CSF PCR is positive for JC virus. What is the most appropriate management?", "options": ["Reduce immunosuppression and initiate intravenous cidofovir", "Immediate exchange transfusion to reduce tacrolimus levels", "Switch from mycophenolate to everolimus and add mirtazapine", "Administer brincidofovir and intravenous immunoglobuli", "Empiric treatment with pyrimethamine/sulfadiazine for toxoplasmosis"], "answer": "C", "answer_index": 2, "explanation": "This is progressive multifocal leukoencephalopathy (PML) in an immunocompromised host. The cornerstone is reducing immunosuppression, specifically switching from mycophenolate (which strongly inhibits T-cell function) to everolimus (which has anti-neoplastic properties and may slow PML progression). Mirtazapine has shown potential benefit by blocking 5-HT2A receptors that JC virus uses for entry. Cidofovir is ineffective against JC virus. Exchange transfusion is not indicated. Antitoxoplasma therapy would be incorrect with positive JC virus PCR.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: 65-year-old transplant recipient on triple immunosuppression, altered mental status, focal deficits, ring-enhancing lesions with eccentric target sign, CSF PCR positive for JC virus - classic for PML. The question asks for 'most appropriate management.' The fundamental principle of PML management is immune reconstitution by reducing overall immunosuppression burden. Option A (reduce immunosuppression) directly addresses this cornerstone, though cidofovir is indeed ineffective against JC virus. Option C (the keyed answer) proposes switching mycophenolate to everolimus plus mirtazapine. While this maintains immunosuppression at similar levels rather than reducing it, the evidence for everolimus benefit in PML is limited, and mirtazapine's 5-HT2A receptor blockade remains investigational with weak evidence. The key medical issue: the rationale incorrectly prioritizes unproven adjunctive therapies over the established primary intervention of reducing immunosuppression. Option A better aligns with standard PML management despite cidofovir being ineffective. Options B, D, E are clearly inappropriate. Minimal fix: Change key to A and revise rationale to emphasize immune reconstitution as primary goal, or rewrite option C to explicitly state 'reduce overall immunosuppression and switch to everolimus.'\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: 65-year-old transplant recipient on triple immunosuppression, altered mental status, focal deficits, ring-enhancing lesions with eccentric target sign, CSF PCR positive for JC virus - classic for PML. The question asks for 'most appropriate management.' The fundamental principle of PML management is immune reconstitution by reducing overall immunosuppression burden. Option A (reduce immunosuppression) directly addresses this cornerstone, though cidofovir is indeed ineffective against JC virus. Option C (the keyed answer) proposes switching mycophenolate to everolimus plus mirtazapine. While this maintains immunosuppression at similar levels rather than reducing it, the evidence for everolimus benefit in PML is limited, and mirtazapine's 5-HT2A receptor blockade remains investigational with weak evidence. The key medical issue: the rationale incorrectly prioritizes unproven adjunctive therapies over the established primary intervention of reducing immunosuppression. Option A better aligns with standard PML management despite cidofovir being ineffective. Options B, D, E are clearly inappropriate. Minimal fix: Change key to A and revise rationale to emphasize immune reconstitution as primary goal, or rewrite option C to explicitly state 'reduce overall immunosuppression and switch to everolimus.'", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-011", "question": "A 34-year-old woman presents with progressive visual field loss. MRI reveals a large suprasellar mass extending into the third ventricle with homogeneous enhancement. Endoscopic biopsy shows a mixed glial and neuronal tumor with neurocytic rosettes and perivascular pseudorosettes. Genetic analysis demonstrates BRAF V600E mutation. What is the most appropriate surgical strategy?", "options": ["Attempt gross total resection via endoscopic endonasal approach", "Subtotal resection followed by targeted BRAF inhibitor therapy", "Open craniotomy with interhemispheric transcallosal approach", "Lateral ventricle endoscopic resection with third ventriculostomy", "Stereotactic biopsy followed by conformal radiotherapy"], "answer": "B", "answer_index": 1, "explanation": "The histology describes a papillary glioneuronal tumor, a low-grade neoplasm with favorable prognosis. When BRAF V600E mutation is present, targeted therapy with BRAF inhibitors can achieve significant tumor reduction with less surgical morbidity compared to aggressive resection for this deeply located tumor. Gross total resection risks hypothalamic injury given the suprasellar location. Radiotherapy is reserved for progressive disease after medical therapy. The transcallosal approach would provide inadequate exposure for this primarily suprasellar lesion.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but the key is incorrect. The vignette describes a large suprasellar mass with mixed glial-neuronal tumor showing neurocytic rosettes and perivascular pseudorosettes, consistent with papillary glioneuronal tumor or central neurocytoma. Key stem clues: 34-year-old with progressive visual field loss, large suprasellar mass extending into third ventricle, BRAF V600E mutation present. The critical issue is that for symptomatic large tumors causing progressive visual loss, surgical resection remains first-line treatment regardless of BRAF mutation status. BRAF inhibitors are not established first-line therapy for these tumors; they are investigational or used for recurrent/progressive disease after surgery. Option B (subtotal resection + BRAF inhibitor) inappropriately prioritizes medical therapy over definitive surgical management for a symptomatic, resectable tumor. Option C (open craniotomy with interhemispheric transcallosal approach) is the correct answer for accessing a suprasellar mass extending into the third ventricle - this approach provides excellent exposure for such lesions. The rationale incorrectly states transcallosal approach provides inadequate exposure; it is actually standard for third ventricular/suprasellar masses. Medical accuracy issue: misrepresents role of BRAF inhibitors as primary therapy. Minimal fix: Change key to C or clarify that tumor is unresectable/recurrent to justify medical therapy first.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but the key is incorrect. The vignette describes a large suprasellar mass with mixed glial-neuronal tumor showing neurocytic rosettes and perivascular pseudorosettes, consistent with papillary glioneuronal tumor or central neurocytoma. Key stem clues: 34-year-old with progressive visual field loss, large suprasellar mass extending into third ventricle, BRAF V600E mutation present. The critical issue is that for symptomatic large tumors causing progressive visual loss, surgical resection remains first-line treatment regardless of BRAF mutation status. BRAF inhibitors are not established first-line therapy for these tumors; they are investigational or used for recurrent/progressive disease after surgery. Option B (subtotal resection + BRAF inhibitor) inappropriately prioritizes medical therapy over definitive surgical management for a symptomatic, resectable tumor. Option C (open craniotomy with interhemispheric transcallosal approach) is the correct answer for accessing a suprasellar mass extending into the third ventricle - this approach provides excellent exposure for such lesions. The rationale incorrectly states transcallosal approach provides inadequate exposure; it is actually standard for third ventricular/suprasellar masses. Medical accuracy issue: misrepresents role of BRAF inhibitors as primary therapy. Minimal fix: Change key to C or clarify that tumor is unresectable/recurrent to justify medical therapy first.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-012", "question": "A 72-year-old man with metastatic castration-resistant prostate cancer to bones undergoes palliative radiotherapy to a symptomatic lumbar spine metastasis (8 Gy × 1). Two weeks later, he develops sudden onset bilateral lower extremity weakness and numbness. MRI shows new T2 hyperintensity in the thoracolumbar cord extending beyond the radiation field. What is the most likely diagnosis?", "options": ["Radiation myelopathy", "Leptomeningeal carcinomatosis", "Paraneoplastic myelitis associated with anti-amphiphysin antibodies", "Spinal cord infarction from tumor embolus", "Subacute combined degeneration from B12 deficiency"], "answer": "C", "answer_index": 2, "explanation": "This presentation describes a paraneometric myelitis triggered by radiation-induced tumor cell death releasing antigens, not direct radiation toxicity (which occurs after longer latency and respects radiation fields). Prostate cancer is associated with anti-amphiphysin antibodies that can cause myelitis. Leptomeningeal disease would show enhancement on MRI. Radiation myelopathy typically presents 6-24 months post-treatment. Cord infarction would have acute dramatic onset rather than subacute progression.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: The keyed answer (C, paraneoplastic myelitis) is not the best answer; the item is miskeyed. Key stem clues: 72-year-old with metastatic prostate cancer, palliative radiotherapy (8 Gy × 1) to lumbar spine, sudden bilateral lower extremity weakness/numbness TWO WEEKS post-radiation, MRI showing T2 hyperintensity extending BEYOND the radiation field. The rationale claims paraneoplastic myelitis triggered by radiation-induced tumor antigen release, but this mechanism is not established in medical literature. Anti-amphiphysin antibodies are classically associated with breast cancer and stiff-person syndrome, NOT prostate cancer or myelitis. The 2-week timeframe and extension beyond the radiation field actually argue AGAINST early transient radiation myelopathy but the acute presentation with bilateral symptoms in a patient with known spinal metastases most strongly suggests acute spinal cord compression or vascular event (option D: cord infarction from tumor embolus is plausible given metastatic disease). Leptomeningeal disease (B) would show enhancement. Radiation myelopathy (A) typically occurs months to years later. The paraneoplastic explanation lacks medical validity. Main medical accuracy issue: incorrect antibody-cancer association and unsubstantiated pathophysiologic mechanism. Minimal fix: Change key to D or rewrite vignette to support a different diagnosis with appropriate clinical features.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer (C, paraneoplastic myelitis) is not the best answer; the item is miskeyed. Key stem clues: 72-year-old with metastatic prostate cancer, palliative radiotherapy (8 Gy × 1) to lumbar spine, sudden bilateral lower extremity weakness/numbness TWO WEEKS post-radiation, MRI showing T2 hyperintensity extending BEYOND the radiation field. The rationale claims paraneoplastic myelitis triggered by radiation-induced tumor antigen release, but this mechanism is not established in medical literature. Anti-amphiphysin antibodies are classically associated with breast cancer and stiff-person syndrome, NOT prostate cancer or myelitis. The 2-week timeframe and extension beyond the radiation field actually argue AGAINST early transient radiation myelopathy but the acute presentation with bilateral symptoms in a patient with known spinal metastases most strongly suggests acute spinal cord compression or vascular event (option D: cord infarction from tumor embolus is plausible given metastatic disease). Leptomeningeal disease (B) would show enhancement. Radiation myelopathy (A) typically occurs months to years later. The paraneoplastic explanation lacks medical validity. Main medical accuracy issue: incorrect antibody-cancer association and unsubstantiated pathophysiologic mechanism. Minimal fix: Change key to D or rewrite vignette to support a different diagnosis with appropriate clinical features.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-013", "question": "A 58-year-old man undergoes left lower lobectomy for stage IIA NSCLC. On postoperative day 2, he develops productive cough and low-grade fever. Chest tube output increases to 450 mL/day of serosanguinous fluid. Fluid analysis shows pH 7.25, glucose 45 mg/dL, LDH 485 U/L. What is the most appropriate management?", "options": ["Insertion of a second chest tube", "Immediate return to operating room for exploration", "Initiation of broad-spectrum antibiotics alone", "Video-assisted thoracoscopic drainage and pleural irrigation", "Observation with repeat chest radiograph in 24 hours"], "answer": "D", "answer_index": 3, "explanation": "The fluid characteristics (low pH, low glucose, elevated LDH) indicate an early empyema or complicated parapneumonic effusion. VATS allows direct visualization, breakdown of loculations, thorough irrigation, and precise tube placement. A second chest tube may not address localized infection. Reoperation is premature without attempted minimally invasive drainage. Antibiotics alone won't drain the infected space. Observation risks progression to fibrinopurulent stage.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a postoperative patient with productive cough, fever, and chest tube output showing fluid with pH 7.25, glucose 45 mg/dL, and LDH 485 U/L. These findings suggest complicated parapneumonic effusion or early empyema. However, critical details are missing: (1) chest imaging findings (loculations, residual space, lung re-expansion status), (2) whether the existing chest tube is functioning properly, (3) clinical severity/sepsis indicators, and (4) timing considerations (POD 2 is very early for empyema post-lobectomy). The keyed answer (D, VATS) assumes loculated/organized fluid requiring surgical intervention, but this cannot be determined from the vignette alone. Option A (second chest tube) could be appropriate if imaging shows simple fluid collection with inadequate drainage. Option C (antibiotics) might suffice if the existing tube drains adequately and no loculations exist. The distinction between VATS versus simpler interventions requires imaging data not provided. Medical accuracy: The fluid parameters and VATS rationale are correct for established empyema, but applying VATS on POD 2 without documented loculations or failed conservative management is aggressive. Minimal fix: Add chest CT/radiograph findings showing loculated fluid collection despite functioning chest tube to justify VATS as the unique best answer.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a postoperative patient with productive cough, fever, and chest tube output showing fluid with pH 7.25, glucose 45 mg/dL, and LDH 485 U/L. These findings suggest complicated parapneumonic effusion or early empyema. However, critical details are missing: (1) chest imaging findings (loculations, residual space, lung re-expansion status), (2) whether the existing chest tube is functioning properly, (3) clinical severity/sepsis indicators, and (4) timing considerations (POD 2 is very early for empyema post-lobectomy). The keyed answer (D, VATS) assumes loculated/organized fluid requiring surgical intervention, but this cannot be determined from the vignette alone. Option A (second chest tube) could be appropriate if imaging shows simple fluid collection with inadequate drainage. Option C (antibiotics) might suffice if the existing tube drains adequately and no loculations exist. The distinction between VATS versus simpler interventions requires imaging data not provided. Medical accuracy: The fluid parameters and VATS rationale are correct for established empyema, but applying VATS on POD 2 without documented loculations or failed conservative management is aggressive. Minimal fix: Add chest CT/radiograph findings showing loculated fluid collection despite functioning chest tube to justify VATS as the unique best answer.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-014", "question": "A 68-year-old woman with a history of thoracic endovascular aortic repair (TEVAR) for descending aortic aneurysm presents with hoarseness and dysphagia. Barium swallow shows external compression of the esophagus without mucosal abnormality. Which management strategy addresses the most likely etiology while minimizing procedural risk?", "options": ["Revision TEVAR with proximal extension", "Direct laryngoscopy with vocal cord medialization", "Esophageal stent placement", "CT angiography of the chest with 3D reconstruction", "Open surgical aneurysm repair via left thoracotomy"], "answer": "D", "answer_index": 3, "explanation": "Hoarseness suggests recurrent laryngeal nerve palsy, and dysphagia indicates mechanical compression-findings consistent with a newly enlarging aortic aneurysm at the TEVAR landing zone causing mass effect. CTA provides definitive evaluation of aneurysm size and relationship to adjacent structures. Endoscopy may show compression but cannot characterize the extracesophageal cause. Revision TEVAR or open repair would be premature without demonstrating aneurysm growth. Mere observation misses the opportunity for timely intervention if expansion is confirmed.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - diagnostic imaging is not a management strategy. The stem asks for a \\\"management strategy\\\" that \\\"addresses the most likely etiology while minimizing procedural risk.\\\" Key discriminating findings: post-TEVAR patient with hoarseness (recurrent laryngeal nerve palsy) and dysphagia with external esophageal compression on barium swallow, suggesting aneurysm expansion/endoleak at TEVAR site. The most likely etiology is aneurysm-related mass effect. While the rationale correctly identifies that CTA is needed for evaluation, diagnostic imaging is not a management strategy - it is a diagnostic step. The question explicitly asks what \\\"addresses\\\" the etiology, implying therapeutic intervention. Option A (revision TEVAR with proximal extension) is the actual management that addresses aneurysm expansion while minimizing risk compared to open surgery (E). Option D would be appropriate if the question asked \\\"What is the next best step in evaluation?\\\" but not for \\\"management strategy.\\\" The item confuses diagnostic workup with therapeutic management. Minimal fix: Change question stem to \\\"What is the next best step in evaluation?\\\" OR change option D to a therapeutic intervention and make CTA implicit in the workup before any intervention.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - diagnostic imaging is not a management strategy. The stem asks for a \"management strategy\" that \"addresses the most likely etiology while minimizing procedural risk.\" Key discriminating findings: post-TEVAR patient with hoarseness (recurrent laryngeal nerve palsy) and dysphagia with external esophageal compression on barium swallow, suggesting aneurysm expansion/endoleak at TEVAR site. The most likely etiology is aneurysm-related mass effect. While the rationale correctly identifies that CTA is needed for evaluation, diagnostic imaging is not a management strategy - it is a diagnostic step. The question explicitly asks what \"addresses\" the etiology, implying therapeutic intervention. Option A (revision TEVAR with proximal extension) is the actual management that addresses aneurysm expansion while minimizing risk compared to open surgery (E). Option D would be appropriate if the question asked \"What is the next best step in evaluation?\" but not for \"management strategy.\" The item confuses diagnostic workup with therapeutic management. Minimal fix: Change question stem to \"What is the next best step in evaluation?\" OR change option D to a therapeutic intervention and make CTA implicit in the workup before any intervention.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-015", "question": "A 47-year-old woman with situs inversus totalis presents with recurrent episodes of acute pancreatitis. MRCP shows pancreas divisum with Santorinicole in the dorsal duct. Previous minor papilla sphincterotomy provided only temporary relief. What is the most appropriate definitive management?", "options": ["Total pancreatectomy with islet autotransplantation", "Long-term pancreatic stent placement across the minor papilla", "Endoscopic ultrasound-guided gastroenterostomy creation", "Surgical dorsal duct jejunostomy (Puestow procedure)", "Repeat ERCP with extended sphincterotomy and stricture dilation"], "answer": "A", "answer_index": 0, "explanation": "In the setting of situs inversus with complex pancreatic duct anatomy (Santorinicole) and failed sphincterotomy, TP-IAT offers the only definitive solution for recurrent pancreatitis while preserving endocrine function. The anomalous anatomy makes standard drainage procedures (Puestow) technically challenging and less effective. Long-term stenting leads to ductal changes and strictures. EUS-guided drainage would not address the underlying drainage impairment from the Santorinicole.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (Underspecified) leading to K (Miskeyed). Verdict: Miskeyed—the keyed answer is not the most appropriate definitive management given standard practice. The stem describes recurrent acute pancreatitis in a patient with pancreas divisum and a Santorinicole (stone/stricture in the dorsal duct) who failed minor papilla sphincterotomy. Key discriminating findings: (1) pancreas divisum with obstructive pathology (Santorinicole), (2) failed initial endoscopic therapy, (3) situs inversus (anatomic variant but not necessarily prohibitive for standard procedures). The clinical problem is recurrent pancreatitis from dorsal duct obstruction. Standard definitive management for failed endoscopic therapy in pancreas divisum with stricture/stone is repeat ERCP with extended sphincterotomy and stricture dilation (option E), or surgical drainage if endoscopic options exhausted. Total pancreatectomy with islet autotransplantation (TP-IAT) is reserved for intractable pain from chronic pancreatitis unresponsive to all other therapies—not first-line definitive management after one failed sphincterotomy in recurrent acute pancreatitis. The rationale incorrectly assumes situs inversus makes standard drainage 'technically challenging'—while it complicates approach, it does not preclude repeat endoscopic or surgical drainage. The item is underspecified regarding severity of chronic changes, pain burden, and whether all endoscopic/surgical drainage options were truly exhausted. Minimal fix: clarify that patient has chronic pancreatitis with intractable pain despite maximal endoscopic and surgical drainage attempts, making TP-IAT appropriate.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to K (Miskeyed). Verdict: Miskeyed—the keyed answer is not the most appropriate definitive management given standard practice. The stem describes recurrent acute pancreatitis in a patient with pancreas divisum and a Santorinicole (stone/stricture in the dorsal duct) who failed minor papilla sphincterotomy. Key discriminating findings: (1) pancreas divisum with obstructive pathology (Santorinicole), (2) failed initial endoscopic therapy, (3) situs inversus (anatomic variant but not necessarily prohibitive for standard procedures). The clinical problem is recurrent pancreatitis from dorsal duct obstruction. Standard definitive management for failed endoscopic therapy in pancreas divisum with stricture/stone is repeat ERCP with extended sphincterotomy and stricture dilation (option E), or surgical drainage if endoscopic options exhausted. Total pancreatectomy with islet autotransplantation (TP-IAT) is reserved for intractable pain from chronic pancreatitis unresponsive to all other therapies—not first-line definitive management after one failed sphincterotomy in recurrent acute pancreatitis. The rationale incorrectly assumes situs inversus makes standard drainage 'technically challenging'—while it complicates approach, it does not preclude repeat endoscopic or surgical drainage. The item is underspecified regarding severity of chronic changes, pain burden, and whether all endoscopic/surgical drainage options were truly exhausted. Minimal fix: clarify that patient has chronic pancreatitis with intractable pain despite maximal endoscopic and surgical drainage attempts, making TP-IAT appropriate.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-016", "question": "A 52-year-old man with alcohol-related cirrhosis presents with acute upper GI bleeding. During emergent endoscopy, active spurting is seen from a large duodenal ulcer in the posterior bulb. After epinephrine injection and placement of two through-the-scope clips, bleeding continues. The following day, he develops fever and severe abdominal pain. CT shows retroperitoneal air and fluid tracking along the right psoas muscle. What is the most appropriate management?", "options": ["Angiographic embolization of the gastroduodenal artery", "Emergency laparotomy with duodenal diversion", "Percutaneous drainage of the retroperitoneal collection", "Repeat endoscopy with over-the-scope clip placement", "IV antibiotics and serial abdominal exams"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes a posterior duodenal ulcer perforation into the retroperitoneum following endoscopic intervention. Given the ongoing bleeding and established contamination, definitive surgical management with duodenal diversion (e.g., Graham patch closure with gastrodujunostomy) is required. Angioembolization would address bleeding but not the perforation. Percutaneous drainage cannot control the duodenal leak. Repeat endoscopy is contraindicated with known perforation. Antibiotics alone would lead to uncontrolled sepsis.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option A is the most defensible best answer. Key stem clues: (1) posterior duodenal bulb ulcer with active spurting, (2) failed endoscopic hemostasis (epinephrine + clips), (3) retroperitoneal air/fluid along right psoas indicating contained perforation. The clinical problem is managing refractory bleeding from a posterior duodenal ulcer complicated by contained retroperitoneal perforation. Posterior bulb ulcers classically erode into the gastroduodenal artery. The primary life-threatening issue is ongoing hemorrhage; the retroperitoneal perforation is contained (not free peritoneal). Angiographic embolization (A) addresses the immediate bleeding emergency and is standard for endoscopy-refractory duodenal ulcer hemorrhage, especially with GDA involvement. Emergency laparotomy with duodenal diversion (B, the keyed answer) is extremely morbid, reserved for free perforation with peritonitis or when angioembolization fails/unavailable. The stem describes contained retroperitoneal perforation without peritonitis signs requiring immediate laparotomy. Standard management hierarchy: control bleeding first (angioembolization), then address contained perforation (often conservatively with drainage/antibiotics or delayed surgery if needed). The key incorrectly prioritizes an overly aggressive surgical approach over the established first-line intervention for refractory duodenal ulcer bleeding. Minimal fix: Change key to A or rewrite stem to indicate free perforation with peritonitis requiring immediate surgery.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option A is the most defensible best answer. Key stem clues: (1) posterior duodenal bulb ulcer with active spurting, (2) failed endoscopic hemostasis (epinephrine + clips), (3) retroperitoneal air/fluid along right psoas indicating contained perforation. The clinical problem is managing refractory bleeding from a posterior duodenal ulcer complicated by contained retroperitoneal perforation. Posterior bulb ulcers classically erode into the gastroduodenal artery. The primary life-threatening issue is ongoing hemorrhage; the retroperitoneal perforation is contained (not free peritoneal). Angiographic embolization (A) addresses the immediate bleeding emergency and is standard for endoscopy-refractory duodenal ulcer hemorrhage, especially with GDA involvement. Emergency laparotomy with duodenal diversion (B, the keyed answer) is extremely morbid, reserved for free perforation with peritonitis or when angioembolization fails/unavailable. The stem describes contained retroperitoneal perforation without peritonitis signs requiring immediate laparotomy. Standard management hierarchy: control bleeding first (angioembolization), then address contained perforation (often conservatively with drainage/antibiotics or delayed surgery if needed). The key incorrectly prioritizes an overly aggressive surgical approach over the established first-line intervention for refractory duodenal ulcer bleeding. Minimal fix: Change key to A or rewrite stem to indicate free perforation with peritonitis requiring immediate surgery.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-017", "question": "A 35-year-old woman with tuberous sclerosis complex develops rapidly progressive renal insufficiency. Imaging shows massively enlarged kidneys with innumerable angiomyolipomas, the largest measuring 8 cm. What is the most appropriate intervention to preserve renal function?", "options": ["Selective arterial embolization of the dominant tumors", "Initiation of everolimus therapy", "Bilateral nephrectomy with dialysis initiation", "Cryoablation of the largest angiomyolipomas", "Radical nephrectomy of the more affected kidney"], "answer": "B", "answer_index": 1, "explanation": "In TSC with diffuse angiomyolipomatosis causing renal failure, everolimus (an mTOR inhibitor) is first-line therapy as it targets the underlying pathophysiology, can reduce tumor size by over 50%, and preserves renal function better than procedural interventions. Embolization or ablation would be impractical for innumerable tumors and could accelerate renal decline. Nephrectomy should be avoided unless absolutely necessary for hemorrhage control. Everolimus addresses the systemic nature of TSC renal involvement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 35-year-old woman with TSC presenting with rapidly progressive renal insufficiency and massively enlarged kidneys with innumerable angiomyolipomas (largest 8 cm). Key discriminating findings: (1) TSC with diffuse bilateral disease (\\\"innumerable\\\" tumors), (2) rapidly progressive renal insufficiency, (3) bilateral massive kidney enlargement. The clinical problem is selecting the intervention that best preserves renal function in diffuse TSC-related angiomyolipomatosis. Everolimus (B) is the correct answer: mTOR inhibitors directly target TSC pathophysiology (TSC1/TSC2 mutations lead to mTOR hyperactivation), can shrink angiomyolipomas by 50%+, and preserve renal function in diffuse disease. Alternative assessment: (A) Embolization is impractical for \\\"innumerable\\\" tumors and risks further renal damage; (C) bilateral nephrectomy eliminates renal function entirely; (D) cryoablation cannot address diffuse bilateral disease; (E) unilateral nephrectomy removes functional tissue without addressing contralateral disease. The keyed answer aligns with current guidelines (everolimus FDA-approved for TSC-associated angiomyolipomas). No logical flaws or medical inaccuracies. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 35-year-old woman with TSC presenting with rapidly progressive renal insufficiency and massively enlarged kidneys with innumerable angiomyolipomas (largest 8 cm). Key discriminating findings: (1) TSC with diffuse bilateral disease (\"innumerable\" tumors), (2) rapidly progressive renal insufficiency, (3) bilateral massive kidney enlargement. The clinical problem is selecting the intervention that best preserves renal function in diffuse TSC-related angiomyolipomatosis. Everolimus (B) is the correct answer: mTOR inhibitors directly target TSC pathophysiology (TSC1/TSC2 mutations lead to mTOR hyperactivation), can shrink angiomyolipomas by 50%+, and preserve renal function in diffuse disease. Alternative assessment: (A) Embolization is impractical for \"innumerable\" tumors and risks further renal damage; (C) bilateral nephrectomy eliminates renal function entirely; (D) cryoablation cannot address diffuse bilateral disease; (E) unilateral nephrectomy removes functional tissue without addressing contralateral disease. The keyed answer aligns with current guidelines (everolimus FDA-approved for TSC-associated angiomyolipomas). No logical flaws or medical inaccuracies. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-018", "question": "A 6-month-old boy presents with recurrent sinopulmonary infections, failure to thrive, and absent lymph nodes on examination. Flow cytometry shows profoundly decreased T cells with normal B cell numbers. Mitogen proliferation assays show no response. Genetic testing reveals a missense mutation in the ORAI1 gene. What specific immunologic defect is present?", "options": ["Defective thymic epithelial development", "Impaired VDJ recombination in T cell receptors", "Absence of stores operated calcium entry", "Mutation in the ζ-chain-associated protein kinase", "Adenosine deaminase deficiency with metabolic toxicity"], "answer": "C", "answer_index": 2, "explanation": "ORAI1 encodes a calcium release-activated calcium channel essential for store-operated calcium entry (SOCE), which is critical for T cell activation, cytokine production, and immune function. Without SOCE, T cells cannot properly activate despite normal development, explaining the severe combined immunodeficiency presentation with normal lymphocyte numbers but functional impairment. This is distinct from recombination defects (RAG, Artemis) or metabolic deficiencies (ADA). The ORAI1 mutation specifically disrupts calcium signaling after T cell receptor engagement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 6-month-old with recurrent infections, failure to thrive, absent lymph nodes, profoundly decreased T cells, normal B cells, absent mitogen response, and ORAI1 mutation. The question asks for the specific immunologic defect. Key discriminating findings: ORAI1 mutation is explicitly stated, which directly encodes the CRAC channel mediating store-operated calcium entry (SOCE). This creates a functional T cell defect despite normal development. Option C correctly identifies absence of SOCE as the defect. Option A (thymic epithelial defect) would present with structural thymic abnormalities, not seen with ORAI1. Option B (VDJ recombination defect) would affect both T and B cells and is associated with RAG/Artemis mutations. Option D (ZAP70 deficiency) presents differently with CD8 deficiency. Option E (ADA deficiency) causes metabolic toxicity affecting both T and B cells with accumulation of toxic metabolites. The stem provides sufficient detail (specific gene mutation) to identify a unique best answer. Medical accuracy is high; ORAI1-SOCE deficiency is well-established as causing SCID with this phenotype. No fix needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 6-month-old with recurrent infections, failure to thrive, absent lymph nodes, profoundly decreased T cells, normal B cells, absent mitogen response, and ORAI1 mutation. The question asks for the specific immunologic defect. Key discriminating findings: ORAI1 mutation is explicitly stated, which directly encodes the CRAC channel mediating store-operated calcium entry (SOCE). This creates a functional T cell defect despite normal development. Option C correctly identifies absence of SOCE as the defect. Option A (thymic epithelial defect) would present with structural thymic abnormalities, not seen with ORAI1. Option B (VDJ recombination defect) would affect both T and B cells and is associated with RAG/Artemis mutations. Option D (ZAP70 deficiency) presents differently with CD8 deficiency. Option E (ADA deficiency) causes metabolic toxicity affecting both T and B cells with accumulation of toxic metabolites. The stem provides sufficient detail (specific gene mutation) to identify a unique best answer. Medical accuracy is high; ORAI1-SOCE deficiency is well-established as causing SCID with this phenotype. No fix needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-019", "question": "A 30-year-old missionary presents with a slowly enlarging scalp lesion after returning from Bolivia. biopsy demonstrates lobulated granulomatous inflammation with rare 5-7 μm budding yeast. Culture on brain-heart infusion agar at 25°C shows cream-colored colonies that convert to yeast form at 37°C. What is the most appropriate antifungal therapy?", "options": ["Itraconazole for 6-12 months", "Amphotericin B lipid complex followed by itraconazole", "Voriconazole indefinitely", "Posaconazole with therapeutic drug monitoring", "Fluconazole for 3-6 months"], "answer": "A", "answer_index": 0, "explanation": "The presentation describes cutaneous granulomas caused by Paracoccidioides brasiliensis, endemic to Latin America. Itraconazole is first-line for non-severe disease, with 6-12 months treatment typically achieving cure. Amphotericin B is reserved for severe disseminated disease. Voriconazole has variable activity against Paracoccidioides. Fluconazole is less effective due to higher relapse rates. The dimorphic growth pattern and geographic history are classic for this infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: 30-year-old from Bolivia with slowly enlarging scalp lesion, biopsy showing lobulated granulomatous inflammation with 5-7 μm budding yeast, dimorphic fungus (cream colonies at 25°C converting to yeast at 37°C). The clinical and microbiologic features strongly suggest Paracoccidioides brasiliensis (paracoccidioidomycosis). However, the organism description is problematic: P. brasiliensis typically shows 8-30 μm yeast with multiple buds (pilot's wheel appearance), not 5-7 μm budding yeast, which better describes Histoplasma capsulatum. If we accept the author's intended diagnosis of paracoccidioidomycosis, itraconazole 6-12 months (Option A) is indeed first-line for mild-moderate cutaneous disease per guidelines. However, the microbiologic description (5-7 μm budding yeast) more accurately describes histoplasmosis, for which itraconazole is also first-line. The fundamental issue is that the yeast size contradicts the intended diagnosis. Main medical accuracy issue: incorrect organism size description creates diagnostic ambiguity. Minimal fix: Change yeast size to '8-30 μm with multiple budding (pilot's wheel)' to unambiguously indicate P. brasiliensis, making Option A clearly correct.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best option. Key stem clues: 30-year-old from Bolivia with slowly enlarging scalp lesion, biopsy showing lobulated granulomatous inflammation with 5-7 μm budding yeast, dimorphic fungus (cream colonies at 25°C converting to yeast at 37°C). The clinical and microbiologic features strongly suggest Paracoccidioides brasiliensis (paracoccidioidomycosis). However, the organism description is problematic: P. brasiliensis typically shows 8-30 μm yeast with multiple buds (pilot's wheel appearance), not 5-7 μm budding yeast, which better describes Histoplasma capsulatum. If we accept the author's intended diagnosis of paracoccidioidomycosis, itraconazole 6-12 months (Option A) is indeed first-line for mild-moderate cutaneous disease per guidelines. However, the microbiologic description (5-7 μm budding yeast) more accurately describes histoplasmosis, for which itraconazole is also first-line. The fundamental issue is that the yeast size contradicts the intended diagnosis. Main medical accuracy issue: incorrect organism size description creates diagnostic ambiguity. Minimal fix: Change yeast size to '8-30 μm with multiple budding (pilot's wheel)' to unambiguously indicate P. brasiliensis, making Option A clearly correct.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-020", "question": "A 42-year-old woman with HIV (CD4 180 cells/μL, viral load undetectable on ART) presents with 2 weeks of progressive neurological decline. MRI shows multiple ring-enhancing lesions with minimal edema. CSF PCR is negative for JC virus, toxoplasma, and CMV. Brain biopsy reveals necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions. What is the most appropriate treatment?", "options": ["High-dose ganciclovir", "Intravenous foscarnet", "Artemisinin combination therapy", "Pyrimethamine plus sulfadiazine", "Cidofovir with probenecid"], "answer": "B", "answer_index": 1, "explanation": "The histopathological findings are characteristic of cytomegalovirus encephalitis, which can present with atypical MRI findings in immunocompromised hosts. Foscarnet is preferred over ganciclovir in this scenario because CMV encephalitis in HIV patients often occurs despite undetectable plasma viral loads, suggesting possible ganciclovir resistance or poor CNS penetration. Foscarnet has different mechanisms of action and better CNS penetration. The negative CSF PCR does not rule out CMV encephalitis due to low viral loads. Arteminsinin and anti-toxoplasma therapies would not address CMV.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: C (Contradiction). Verdict: No defensible answer. The vignette contains an internal contradiction that makes the item unsolvable. The stem explicitly states \\\"CSF PCR is negative for JC virus, toxoplasma, and CMV,\\\" yet the rationale claims the findings are \\\"characteristic of cytomegalovirus encephalitis\\\" and argues that \\\"negative CSF PCR does not rule out CMV.\\\" While it's true that CSF PCR can have false negatives, the biopsy description (\\\"necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions\\\") is actually more consistent with HSV encephalitis or other viral etiologies than CMV. CMV encephalitis typically shows microglial nodules and ventriculoencephalitis, not the described pattern. The \\\"bizarre astrocytes\\\" suggest a different pathology. Given the explicit negative CMV PCR and atypical histology for CMV, foscarnet (B) cannot be defended as the best answer. The item provides contradictory information that prevents identification of any single best treatment. Minimal fix: Either (1) make CSF PCR positive for CMV and adjust histology to match CMV patterns, or (2) revise histology to clearly indicate CMV-specific findings (microglial nodules, periventricular distribution) and explain the PCR discordance more explicitly in the stem.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). Verdict: No defensible answer. The vignette contains an internal contradiction that makes the item unsolvable. The stem explicitly states \"CSF PCR is negative for JC virus, toxoplasma, and CMV,\" yet the rationale claims the findings are \"characteristic of cytomegalovirus encephalitis\" and argues that \"negative CSF PCR does not rule out CMV.\" While it's true that CSF PCR can have false negatives, the biopsy description (\"necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions\") is actually more consistent with HSV encephalitis or other viral etiologies than CMV. CMV encephalitis typically shows microglial nodules and ventriculoencephalitis, not the described pattern. The \"bizarre astrocytes\" suggest a different pathology. Given the explicit negative CMV PCR and atypical histology for CMV, foscarnet (B) cannot be defended as the best answer. The item provides contradictory information that prevents identification of any single best treatment. Minimal fix: Either (1) make CSF PCR positive for CMV and adjust histology to match CMV patterns, or (2) revise histology to clearly indicate CMV-specific findings (microglial nodules, periventricular distribution) and explain the PCR discordance more explicitly in the stem.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}]